Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

Cirtran (CIRX) Gains from Investment Securities (2019 - 2022)

Historic Gains from Investment Securities for Cirtran (CIRX) over the last 7 years, with Q4 2022 value amounting to $30000.0.

  • Cirtran's Gains from Investment Securities changed 0.0% to $30000.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $30000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $7222.0 for FY2024, which is N/A changed from last year.
  • Latest data reveals that Cirtran reported Gains from Investment Securities of $30000.0 as of Q4 2022, which was down 0.0% from $30000.0 recorded in Q4 2021.
  • In the past 5 years, Cirtran's Gains from Investment Securities registered a high of $30000.0 during Q4 2021, and its lowest value of -$9771.0 during Q1 2020.
  • For the 4-year period, Cirtran's Gains from Investment Securities averaged around $9352.4, with its median value being $7000.0 (2019).
  • As far as peak fluctuations go, Cirtran's Gains from Investment Securities plummeted by 26285.0% in 2020, and later surged by 18187.49% in 2021.
  • Cirtran's Gains from Investment Securities (Quarter) stood at $8000.0 in 2019, then changed by 0.0% to $8000.0 in 2020, then skyrocketed by 275.0% to $30000.0 in 2021, then changed by 0.0% to $30000.0 in 2022.
  • Its Gains from Investment Securities was $30000.0 in Q4 2022, compared to $30000.0 in Q4 2021 and $6000.0 in Q3 2021.